Knight Therapeutics Announces Canadian Commercial Launch of IBSRELA™ – New Innovative Treatment for Irritable Bowel Syndrome with Constipation

Knight Therapeutics, Inc. announced the Canadian commercial availability of IBSRELA, a first-in-class therapy for the treatment of IBS with constipation in adults.